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Discovery of unidentified protein functions is of biological
importance because it often provides new paradigms for many
research areas. Mammalian heme oxygenase (HO) enzyme cat-
alyzes theO2-dependent degradation of heme into carbonmon-
oxide (CO), iron, and biliverdin through numerous reaction
intermediates. Here, we report that H2S, a gaseous signaling
molecule, is part of a novel reaction pathway that drastically
alters HO’s products, reaction mechanism, and catalytic prop-
erties. Our prediction of this interplay is based on the unique
reactivity of H2S with one of the HO intermediates. We found
that in the presence of H2S, HO produces new linear tetrapyr-
roles, which we identified as isomers of sulfur-containing biliv-
erdin (SBV), and that onlyH2S, but not GSH, cysteine, and poly-
sulfides, induces SBV formation. As BV is converted to bilirubin
(BR), SBV is enzymatically reduced to sulfur-containing biliru-
bin (SBR), which shares similar properties such as antioxidative
effects with normal BR. SBR was detected in culture media of
mouse macrophages, confirming the existence of this H2S-in-
duced reaction in mammalian cells. H2S reacted specifically
with a ferric verdoheme intermediate of HO, and verdoheme
cleavage proceeded through an O2-independent hydrolysis-like
mechanism. This change in activation mode diminished O2 de-
pendence of the overall HO activity, circumventing the rate-
limitingO2 activation ofHO.Wepropose thatH2S could largely
affect O2 sensing bymammalianHO, which is supposed to relay
hypoxic signals by decreasing CO output to regulate cellular
functions. Moreover, the novel H2S-induced reaction identified
here helps sustain HO’s heme-degrading and antioxidant-gen-
erating capacity under highly hypoxic conditions.
Hydrogen sulfide (H2S) has emerged as the third gaseous
mediator molecule alongside nitric oxide (NO) and carbon
monoxide (CO) in mammalian signaling to modulate a variety
of biological processes (1–6). H2S is endogenously synthesized
by cystathionine -synthase (CBS),3 cystathionine -lyase, and
3-mercaptopyruvate sulfurtransferase. Among the gaseous
mediators, only H2S can be ionized in aqueous solution to exist
mainly as itsmonoanion form (SH) with negligible amounts of
S2 present under physiological pH (pKa values for H2S and
SH are 7.0 and17, respectively) (6). The SH anion is known
to possess high reducing ability and nucleophilicity. One of the
most established targets of SH is a cysteine residue of proteins
to form persulfide (–SSH). Functions of target proteins such as
ATP-dependent potassium (KATP) channels (1) are modulated
by the covalent modification, which may proceed through
nucleophilic attack of SH to oxidized forms of the cysteine
residue, although the detailed mechanism has yet to be identi-
fied (7). In addition, SH is reported to react with a variety of
small biomolecules to afford reactive sulfur species, including
polysulfides (Sn2) (6, 8, 9). Considering these unique reactivi-
ties, H2S could have further signaling targets, whose identifica-
tion is crucial for the H2S biology. We have envisaged a new
interplay of H2S within the gaseous mediator systems because
of their tight interactions, especially in vasorelaxation and oxy-
gen (O2) sensing. For instance, CObinding to a prosthetic heme
of CBS inhibits the H2S synthesis to cause vasoconstriction in
neurovascular units (10). The biological source of CO is heme
degradation catalyzed by heme oxygenase (HO), which exists as
two isoforms, inducible HO-1 and constitutive HO-2 (11). HO
activity could haveO2dependence that is a prerequisite to func-
tion as a primary O2 sensor in the cerebral blood vessels as well
as in the carotid body (10, 12). These intricate interplaysmay be
an inherent feature of the gaseous mediators and suggest the
existence of further unidentified cross-talk. Here, we report
that H2S opens a novel pathway of HO to produce a new heme
catabolite.
The newHO reaction, termed an S-HO reaction hereafter, is
predicted on the basis of mechanistic knowledge of HO cataly-
Thisworkwas supportedbyGrants-in-aid for Scientific Research2412006and
24350081 (to M. I.-S.); 23550186, 25109504, 15K05555, and 15H00912 (to
T. M.); and 17H04000 (to T. H.) from the Japan Society for the Promotion of
Science (JSPS) and Ministry of Education, Culture, Sports, Science and
Technology (MEXT), Japan; by Takeda Science Foundation; and by Strate-
gic Alliance Project for the Creation of Nano-Materials, and Nano-devices
and Nano-systems from MEXT, Japan. The authors declare that they have
no conflicts of interest with the contents of this article.
This article was selected as one of our Editors’ Picks.
This article contains Figs. S1–S9 and Tables S1 and S2.
1 Towhom correspondencemay be addressed. Tel. and Fax: 81-22-217-5117;
E-mail: toshitaka.matsui.d5@tohoku.ac.jp.
2 Towhom correspondencemay be addressed. Tel. and Fax: 81-22-217-5117;
E-mail: mis2@tagen.tohoku.ac.jp.
3 The abbreviations used are: CBS, cystathionine -synthase; BV, biliverdin;
BR, bilirubin; SBV, sulfur-containing biliverdin; SBR, sulfur-containing bili-
rubin; HO, heme oxygenase; CPR, cytochrome P450 reductase; BVR, biliv-
erdin reductase; AAPH, 2,2-azobis(2-amidinopropane) dihydrochloride;
ESI, electrospray ionization.
croEDITORS’ PICK
J. Biol. Chem. (2018) 293(43) 16931–16939 16931
© 2018 Matsui et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.
 at TO
H
O
K
U
 U
N
IV
ERSITY
 on N
ovem
ber 28, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
sis as well as H2S reactivity. HO catalyzes degradation of heme
into biliverdin (BV), ferrous iron, and CO by three successive
monooxygenation steps via hydroxyheme and verdoheme
intermediates (see Fig. 1A) (13, 14). These O2 activation steps
are performed by the substrate heme itself, so that HO catalysis
actually involves numerous reaction intermediates (Fig. S1) (13,
14). Among them, we have initially postulated the verdoheme
intermediate, which may exist in either a ferric or ferrous state
(Fig. S1), as a potential target of H2S. In the enzymatic reaction,
themacrocycle of verdoheme is cleaved by reductive O2 activa-
tion on its central iron (15, 16). Anomalously slow O2 binding
on ferrous verdoheme is regarded as a major rate-determining
step of HO to achieve the O2 dependence of its overall activity
(15, 17). The other two O2 reactions with heme and hydroxy-
heme are not rate-limiting because of their high reactivity
and/or affinity (18, 19). Chemically, the verdoheme ring could
be cleaved even by O2-independent hydrolysis (20). Although
the verdoheme hydrolysis proceeds only under physiologically
irrelevant, strong alkaline conditions,wehypothesized thatH2S
efficiently promotes “thiolysis,” the hydrolysis-like ring cleav-
age (see Fig. 1A), because of its strong nucleophilicity even
under physiological pH. As expected from the reaction design,
the S-HO reaction is found to produce an unprecedented sul-
fur-containing biliverdin termed S-biliverdin (SBV). H2S reacts
with ferric, but not ferrous, verdohemewith drasticmodulation
of theHO catalytic properties due to circumvention of the rate-
limiting O2 reaction (Fig. 1).
Results
Novel S-HO reaction under single-turnover condition
Effects of H2S on HO catalysis were first examined under
single-turnover conditions where ferric heme complexed with
rat HO-1 was converted once into products. In the absence of
H2S, reduction of ferric heme–HO-1 by its physiological redox
partner, NADPH-cytochrome P450 reductase (CPR), resulted
in an intricate absorption spectral change to eventually afford
BV having intense visible absorption around 688 nm (Fig. 2A)
(21). Temporal emergence of sharp absorption at 641 nm is due
to transient accumulation ofCO-bound verdoheme (Fig. S1). In
the presence of H2S, the starting heme complex showed a spec-
tral shift typical for partial binding of H2S to the ferric heme
iron (Fig. 2B) (22). The heme degradation with H2S proceeded
through distinct intermediate(s) absorbing around 754 nm to
yield product(s) having broader absorption at 697 nm.
Although H2S hardly affected amounts of CO produced
through the heme degradation (Fig. S4D), HPLC analysis
detected two new products other than BV in the presence of
H2S (Fig. 2D), whose absorption spectra are similar to each
other but different from that of BV (Fig. S4A). Further product
analysis identified these twonewproducts as SBV regioisomers,
1-SBV and 19-SBV (Fig. 1B). Positive mass signals of the new
products were both found at 599.24 (Fig. S4C), consistent with
the SBV formula ([C33H34O5N4S  H]; calculated m/z,
599.23). Isotope labeling experiments revealed incorporation of
one each atom of oxygen and sulfur into the new products,
whereas BV accepts two oxygen atoms from O2 at the cleavage
site (Table S1). 1-SBV and 19-SBV standards synthesized
according to a previous report (23) (Figs. S2 and S3) are indis-
tinguishable from the two new products in terms of the HPLC
retention time (Fig. 2D) and absorption spectra (Fig. S4, A and
B). These results strongly suggest H2S-dependent ring cleavage
as hypothesized.
Formation and properties of SBR
In mammals, BV is rapidly reduced by biliverdin reductase
(BVR) to a yellow pigment, bilirubin (BR; Fig. 1C and Fig. S4E).
The single turnover reaction of the purified HO enzyme with
additional BVR yielded BR having typical absorption around
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462 nm (Fig. 2C). The SBV standards were also reduced by BVR
to corresponding 1- and 19-SBR isomers (Fig. 1C), whose
absorption peakswere observed around 530 nm to have distinct
orange colors (Fig. S4, E–G). Structures of the SBR isomers
were further confirmed by various product analyses (Fig. S5,
A–C and Table S2). Due to the large red shifts of the absorption
bands, the SBR formation under the single-turnover condition
is easily visualized by an unusual shoulder around 530 nm (Fig.
2C). The single turnover rate slightly decreased in the presence
ofH2S as judged by absorbance increase either at 460 or 530 nm
(approximately half; Fig. 2C).
SBR is also produced by a macrophage cell line, RAW264.7.
This cell line is reported to secrete BR into cell culture media
when incubated with hemin (24). Our HPLC analysis detected
only BR as a product of the normal heme catabolism by
RAW264.7 (Fig. 2E). Addition of H2S, however, resulted in
the formation of the two SBR isomers as well as BR (Fig. 2E),
assuring the progression of the S-HO reaction inmammalian
cells.
The SBR isomers share similar properties with BR as
expected from their structural similarity (Fig. 1C). Highly
hydrophobic SBR and BR require bovine serum albumin
(BSA) for their solubilization in neutral buffers. BR is known
to be excreted into bile upon glucuronidation in liver (Fig.
S5D) (25). Both isomers of SBR were similarly converted by
UGT1A1 to their mono- and diglucuronides (Fig. S5, E–G).
BR is also proposed to be a potent antioxidant through a
redox cycling with BV (Fig. S6A) (26, 27). Catalytic removal
of radical species was suggested for BR and the SBR iso-
mers in the 2,2-azobis(2-amidinopropane) dihydrochloride
(AAPH) assay (Fig. S6), implying their comparable potencies
as antioxidants.
Catalytic properties of the S-HO reaction
TheH2S effects onHO catalytic properties were examined in
the presence of BVR (17). As shown in Fig. 2F, the product ratio
of total SBR over all three products (%SBR) rose as the H2S
concentration increased (EC50  34 M). To our surprise, the
catalytic activity of HO-1 was severely suppressed by H2S (Fig.
2F; IC50 48M) despite its small effect on the single turnover
rate (Fig. 2C). Although the EC50 and IC50 values are similar at
the basal condition ([CPR] 100nM), these parameters showed
distinct behavior when the CPR concentration was lowered to
20 nM (EC50 and IC50  9.6 and 200 M, respectively). This
observation reveals different mechanisms for the SBR induc-
tion and HO inhibition by H2S. It should also be noted that
%SBR was saturated at 45% under normal air. Incomplete
formation of SBR is due, at least in part, to an unexpected action
ofO2 because%SBR increasedwith loweringO2 concentrations
(Fig. 2G). O2 dependence of the catalytic activity was also
largely affected byH2S (Fig. 2G). The normalHO reactionwith-
out H2S was slowed down at O2 concentrations less than 130
M due to the rate-limiting reaction of the ferrous verdoheme
intermediate with O2 (Fig. 1A) (15, 17). In contrast, very little
O2 dependencewas observed in the presence ofH2S, consistent
with circumvention of the slow O2-dependent ring cleavage
(Fig. 1A).
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Ferric verdoheme as a branch point intermediate
We finally examined reaction mechanism of the S-HO reac-
tion. In our initial design, H2S was postulated to attack ferrous
verdoheme (Fig. 1A); however, this intermediate showed negli-
gible spectral change upon addition of H2S and CPR under
anaerobic condition (Fig. S7A). Further O2 addition initiated
the reaction but afforded only BR (Fig. S7A). Instead,more elec-
trophilic ferric verdoheme, which was generated prior to the
ferrous form (Fig. S1), was found to rapidly react with H2S. The
H2S addition to ferric verdoheme diminished its characteristic
absorption at 683 nm with appearance of featureless, “flat”
absorption in a 600–800-nm range (Fig. 3A). Resulting inter-
mediate X was reduced to yield a mixture of BR and SBR under
normal air, whereas the SBR formation became dominant at
lowerO2 concentration (Fig. 3D), consistentwith theO2depen-
dence of %SBR observed in the catalytic assay (Fig. 2G). Other
HO intermediates generated prior to ferric verdoheme, includ-
ing hydroxyheme (Fig. S1), did not react with H2S or only
reversibly interacted to eventually afford the same intermediate
X (Fig. S7, B–D). These results unambiguously identify ferric
verdoheme as a branch point intermediate for the BV and SBV
pathways of HO as shown in Fig. 4.
Conversion of ferric verdoheme to the intermediate X
required approximately 1 molar eq of H2S (Fig. 3B). Mass anal-
ysis also revealed incorporation of one sulfur atom into ferric
verdoheme (Fig. 3C and Fig. S9A). Apparent rate constants for
the formation of X show pH-dependent transition with a pKa
value of 7.0 (Fig. 3E). This change is attributed to ionization of
H2S (pKa  7.0) because no significant spectral change was
observed for ferric verdoheme in this pH range. The alkaline
form (SH; 29 mM1 s1) was 300-fold more reactive than
the acid form (H2S; 0.094mM1 s1), indicating SH as amajor
reactant. This conclusion rationally explains the low reactivity
of other biological thiols. Glutathione (GSH), L-cysteine, and
homocysteine, which have higher pKa values (9.7, 8.4, and 8.9,
respectively), showed only limited reactivity with ferric verdo-
heme (Fig. S8B). Moreover, these alkyl thiols did not convert
ferric verdoheme to X but reduced it to the ferrous state, lead-
ing to the normal BV pathway (Fig. S8A and Fig. 4). Similar
simple reduction was also observed for sodium polysulfides
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(Na2S2, Na2S3, and Na2S4) as shown in Fig. S8, C andD. There-
fore, H2S is the specific thiol that induces SBV formation.
Ring openingmechanism in the H2S-mediated reaction
Under anoxic conditions, reduction of the intermediate X
dominantly produced SBR (Fig. 3D), strongly suggesting an
O2-independent hydrolysis-like mechanism for the SBV pro-
duction (Fig. 4). In this mechanism, nucleophilic addition of
SH to a -pyrrole carbon atom of ferric verdoheme should be
followed by deprotonation to cleave the macrocycle. A result-
ing Fe3–SBV complex could be reduced by one electron to
afford SBV with release of the ferrous iron. As expected from
this scheme, the anoxic conversion of X to SBR consumed three
electrons, two of which were utilized for reduction of SBV to
SBR (Fig. 3F). In the presence of O2, the mechanism became
more intricate to afford BV in addition to SBV. The BV forma-
tion from X required O2-induced extrusion of the sulfur atom.
X itself has no reactivity with O2 as judged from the negligible
O2 dependence of its absorption spectra (Fig. 3D). Instead, a
reduced formofXmay bindO2 on its central iron to liberate the
SH moiety. This putative reaction yielded oxyferrous verdo-
heme, which is an intermediate proposed in the normal HO
reaction (Fig. 4) (15). The verdoheme regeneration from X is
possible because pyridine extraction of X from the protein
yielded a bispyridine complex of verdoheme (Fig. S9B). It
should be also mentioned that one oxygen atom of O2 was
inserted in the conversion of X to BV (Fig. S9C), consistent with
the O2 activation on the verdoheme iron (15).
Discussion
In this study, we report the new reaction pathway of mam-
malian HO induced by H2S. The gaseous signaling molecule
drastically alters the reaction mechanism of HO not only to
modulate the catalytic activity and its O2 dependence but also
to produce the new sulfur-containing heme catabolites, 1- and
19-SBV isomers (Fig. 1). It is quite surprising that the classical
HO enzyme, whose function andmechanismhave been studied
in detail over several decades, has an unidentified reaction
pathway that is just nowbeing revealed. Recently, noncanonical
heme degradation has also been identified for a few bacterial
enzymes; however, these enzymes are specifically designed to
promote unusual reactions (28–30). We have succeeded in
inducing the alternative reaction of the canonical HO enzyme
by the rational selection of the small biological molecule to
attack its reaction intermediate. H2S appears to have broad
reactivities with many biological compounds. For example,
heme is known to interact with H2S to cause catalytic oxidation
of the sulfide (22) and covalent modification of the heme
periphery to generate sulfheme (31). These reactions appear to
be negligible upon induction of the S-HO reaction (Figs. 2B and
3B), probably due to the facile and specific reactivity of the HO
intermediate with H2S. Our approach to target the enzyme
intermediate thus allows identification of highly specific inter-
actions and could be applied widely to search for hidden func-
tions, especially of well-studied enzymes. Besides the SBVpath-
way, theHO reactionmay branch into unidentified pathways at
its numerous reactive intermediates (Fig. S1) by choosing other
appropriate small molecules. Moreover, H2S could react with
enzymes other than HO to bring out their unidentified reac-
tions. To discover further unknown targets, possible effects of
H2S should be extensively studied for reactions involving hy-
drolysis or a step replaceable with a hydrolysis-type reaction in
addition to searching for electrophilic intermediates.
We have almost fully elucidated the formationmechanism of
SBV. The SH ion binds to ferric verdoheme and cleaves the
macrocycle in an O2-independent manner. The only major
ambiguity remaining is the nature of the observed intermediate
X. The intermediate X generated in the reaction between ferric
verdoheme and H2S can be either an SH–adduct of verdo-
heme or an Fe3–SBV complex (Fig. 4), both of which match
the mass data (Fig. 3C and Fig. S9A). The SH–adduct form
well explains the O2-dependent SH extrusion, whereas ring
closure of Fe3–SBV seems not to occur easily. Neverthe-
less, the absorption spectrum of X, especially its flat absorp-
tion in the visible region, is very similar to that of the
Fe3–BV complex (Fig. 3A and Fig. S9D) (32), strongly sug-
gesting the Fe3–SBV structure for X. The ring closure may
proceedmore easily than we expected to achieve equilibrium
of the open and closed ring structures for X and/or its
reduced form.
Successful detection of SBR assures that the S-HO reaction
can take place in mammalian cells (Fig. 2E). Nevertheless, we
cannot specify the H2S concentration required for the SBV
induction (EC50) in vivo. Our mechanistic analysis identifies
ferric verdoheme as a branch point intermediate for the normal
and SBV pathways (Fig. 4). Because the SH addition and
reduction of ferric verdoheme are essentially irreversible, a
major determinant of the EC50 value should be relative rates of
the two competing reactions. Slower reduction by CPR hence
results in the lowered EC50 value as shown for the in vitro assay.
Some naturally occurring mutations of CPR are known to sig-
nificantly suppress electron transfer to HO (33), probably lead-
ing to hypersensitivity toward H2S. Hypoxia is also expected to
decelerate the electron transfer by inducing liberation of HO
from the endoplasmic reticulum (34). The cytosolic HO
enzyme could interact only weakly with CPR remaining on the
endoplasmic reticulum membrane. The SBV formation could
be enhanced under hypoxia because of the slow reduction as
well as the low O2 concentration. Nonmammalian HOs with
greater diversity in structure and reactivity may have larger
deviations in the H2S requirement to stimulate the S-HO reac-
tion. Even non-HO–type heme-degrading enzymes involving
ferric verdoheme in their catalysis are possible targets of H2S
(35). Our finding clearly indicates the necessity to take the pos-
sible interplay betweenH2S andhemedegradation into account
in all related research areas.
The new S-HO reaction could have large impacts on physio-
logical functions of H2S and HO through drastic changes in
both the product and catalytic activity of HO. Properties of the
new heme catabolites have been examined mainly for their
reduced form, SBR, which as well as BR should be the major
form inmammalian cells. AlthoughBR is crucial inmammals as
a causative agent of jaundice and a potent antioxidant (26), SBR
shows solubility, glucuronidation potency, and redox proper-
ties similar to those of BR (Figs. S5, D–G, and S6). This obser-
vation implies that H2S does not greatly alter antioxidative
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functions of the HO reaction in mammals. Biological roles of
SBV are yet to be examined, especially in biosynthesis of phy-
tochromes and photoreceptor proteins in plants, bacteria, and
fungi, which utilize BVor its derivatives as a pigment for detect-
ing red and far-red light (36).
Our catalytic assay reveals the O2-dependent change of the
SBR production ratio (%SBR) due to the O2-induced return to
the BV pathway (Figs. 2G and 4). Considering the similar prop-
erties of BR and SBR, this product change itself may have a
biological significance only when a receptor system specific to
the new catabolite exists. More importantly, the O2 depen-
dence of the HO activity was lost in the presence of H2S due to
circumvention of the rate-limitingO2 activation by ferrous ver-
doheme (Figs. 2G and 4) (10, 15, 37). This activity change is
expected to have large impacts on gas signaling, namely the O2
sensing in the brain microvessels as well in as the carotid body.
In these systems, HO-2, a constitutive isoform of HO, serves as
a primary oxygen sensor, and its CO product is considered to
transduce the O2 signal in concert with H2S (10, 12, 38). A
major H2S generator in brain is CBS (39), whose prosthetic
heme group binds CO to directly inhibit the enzyme activity
under normoxia (40). CO is also reported to be a physiological
inhibitor of cystathionine -lyase in the carotid body despite
the absence of an apparent CO-binding site (41). Under
hypoxic condition, the HO activity decreases to relieve the CO
inhibition of the H2S-generating enzymes. Consequently,
hypoxia stimulates theH2S synthesis to enhance vasodilation in
brain and neural activity of the carotid body through regulation
of potassium channels (10, 38). The faster formation of H2S
togetherwith its slower decay throughO2-dependent processes
is expected to promote the O2-independent S-HO reaction
under hypoxia (Figs. 2G and 4). This maintains the HO activity
at a certain level even under highly hypoxic conditions to avoid
a complete stop of CO synthesis and thus overproduction of
H2S.AnH2S concentration ceilingmay be important to prevent
respiratory disorder (42) and to reduce its toxicity. Likewise,
under inflammatory conditions in which cytokines activate
macrophages, the cells induce HO-1 (43), which might protect
against oxidative stress through the action of SBV and SBR
under hypoxic conditions.
Another striking effect of H2S is severe suppression of the
HO catalytic activity (Fig. 2F), which is not explained by the
mechanism shown in Fig. 4. Considering the weak inhibition of
the single turnover reaction (Fig. 2C), interference by H2S
appears to occur at a step prior to formation of the heme–HO
complex. Under the catalytic conditions, excess hemin weakly
binds to BSA supplemented to solubilize the BR and SBR prod-
ucts. The hemin–BSA complex exhibits a significant spectral
changewhen incubatedwithH2S under hypoxic conditions but
not under air, suggesting temporal reduction of hemin, O2
binding, and rapid auto-oxidation. This implies catalytic pro-
duction of reactive oxygen species, which may inactivate the
HO enzyme. The inhibitory effect of H2S in vivomight be dis-
tinct from our in vitro observation because it would largely
depend on the status of “free heme” that interacts with various
cellular factor(s).
Experimental procedures
Materials
18O2 and 34S8 were purchased from Spectra Stable Isotope
(18O content, 95%) and ISOFLEX (34S content, 99.9%),
respectively. Liquid NH3 (20 ml) was added dropwise to 34S8
(100 mg, 2.94 mmol) and sodium (135 mg, 5.89 mmol) in a
round-bottom flask at 78 °C. The reaction mixture was
stirred at room temperature under an argon atmosphere until
liquid NH3 entirely vaporized. The residue was dried under
reduced pressure to afford Na234S (anhydrous) as pale yellow
powder (233 mg, quantitative). Microsomes containing human
UGT1A1 and reagents required for glucuronidation were
obtained from BD Gentest. Preparation of rat HO-1, its hemin
complex, human CPR, and BVR was carried out as described
previously (44–46). Other chemicals and proteins were
obtained from Wako, Oriental Yeast, Sigma-Aldrich, or ICN
and used without further purification. RAW264.7 was pur-
chased from the American Type Culture Collection (ATCC).
The basal buffer used throughout this study was 0.1 M HEPES,
pH 7.5, at 20 °C unless otherwise stated.
Heme degradation by purified enzyme systems
Single turnover reactions to yield BV/SBV were typically
examined in the presence of 10 M ferric heme–HO-1, 40 M
NADPH, 40 nMCPR, and varied amounts of H2S. Similar single
turnover reactions for BR/SBRwere supplemented furtherwith
40 nM BVR and 10 M BSA. Catalytic assays were conducted
with 0.25 M HO-1, 10 M hemin, 200 M NADPH, 100 nM
CPR, 25 nMBVR, 15MBSA, 100 units/ml catalase, 10 units/ml
superoxide dismutase, and varied concentrations of H2S. Initial
rates were determined at 20min to assure linear increase of the
products. O2 dependence of the catalytic activity and 18O2
labeling of the products were examined in an anaerobic glove
box (UNIlab,MBraun). Absorption spectral changes during the
reaction were recorded by an Agilent 8453 or Shimadzu
UV-1500 spectrophotometer.
Product analysis of enzymatic reactions
Heme catabolites were concentrated by solid-phase extrac-
tion with Supelclean LC-18 columns (Supelco) as described
elsewhere (15). The BR/SBR extraction was operated under
minimum light to suppress their photoisomerization. Benzo-
phenone was added as an internal standard at the end of the
reactions for quantitative experiments. HPLC analyses of the
extracted products were performed on a Shimadzu LC-20
HPLC system equipped with an SPD-M20A photodiode array
detector at a flow rate of 1.0 ml/min. The BV/SBV products
were separated on a Tosoh ODS-80Ts reversed-phase column
(4.6 150 mm) with an isocratic elution of 70% methanol and
30% 0.1 M ammonium acetate (v/v). The BR/SBR analysis was
performed typically on theODS-80Ts columnwith a linear gra-
dient from 75%methanol, 25% 20mM triethylamine, and acetic
acid (v/v), pH 5.0, to 85% methanol (v/v) over 15 min.
ESI-MS spectra weremeasured on a BrukermicrOTOF-Q-II
mass spectrometer equipped with an Agilent 1100 HPLC sys-
tem at a flow rate of 0.2 ml/min. LC separation of BV/SBV was
conducted on the ODS-80Ts column (2.0  150 mm) with an
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isocratic elution of 20% 0.1 M ammonium acetate and 80%
methanol (v/v). BR/SBR and their glucuronides were analyzed
with an Agilent ZORBAX Extend-C18 reversed-phase column
(2.1 150mm) using a linear gradient from 35%methanol and
65% 20mM aqueous ammonia (v/v) to 50%methanol (v/v) over
20 min. Mass spectra of the intermediate X were measured by
direct infusion at 3 l/min of a reaction solution containing 3
M heme–HO-1, 10 MH2O2, and 20 MH2S. Typical param-
eters for theMSmeasurementswere as follows: end plate offset,
500 V; capillary, 4500 V; in-source collision-induced dissoci-
ation, 150 V; nebulizer gas, 0.4 bar; dry gas, 4.0 liters/min; dry
gas temperature, 180 °C.
COwas quantitated using anH64L variant ofmyoglobin hav-
ing high CO affinity as reported earlier (28). After completion
of single turnover reactions of 4 M heme–HO-1, solid sodium
dithionite and then H64L myoglobin (final concentration, 6
M) were added to record absorption spectra of H64L partially
bound with CO. Subtraction of a spectrum of ferrous H64L
without exogenous ligands generated difference spectra in
which a positive peak indicates generation of the CO-bound
form and a negative peak is due to disappearance of ferrous
deoxy H64L.
Synthesis of 1- and 19-SBV
1- and 19-SBV isomers were synthesized as their dimethyl
esters (total yields fromBV, 22 and 15%, respectively) according
to a previous report (23). 1H and 13C NMR of the dimethyl
esters was measured in CDCl3 with JEOL JMN-LA400 and
JMN-LA600 Fourier transform NMR spectrometers (Figs. S2
and S3). Chemical shifts were referenced internally to CDCl3.
The SBV esters were hydrolyzed, purified, and weighed by a
Sartorius ultra-microbalance SE2 to determine extinction coef-
ficients (Fig. S4, F and G).
Glucuronidation
Approximately 20 M SBV isomers were reduced by BVR to
corresponding SBR isomers in the presence of 20 M NADPH
and 30 M BSA. The freshly prepared SBR was glucuronidated
at 37 °C by BD Supersomes UGT1A1 according to a protocol
provided by the manufacturer. Aliquots of samples were ana-
lyzed by HPLC and ESI-MS.
AAPH assay
Each of 10 M freshly prepared BR and SBR isomers was
incubated at 37 °C with 50 mMAAPH in 0.1 M potassium phos-
phate, pH 7.5, containing 200mMNaCl and 15 M BSAwith or
without 100 M NADPH and 50 nM BVR. Absorption spectral
changes during the reaction were monitored at 468, 541, and
521 nm for BR, 1-SBR, and 19-SBR, respectively.
Heme degradation bymammalian cells
RAW264.7 cells weremaintained in a 37 °C humidified incu-
bator containing 5% CO2 and cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum,
penicillin-streptomycin, and glutamine. 9  106 cells were
grown in a 75-cm2 cell culture flask for 24 h and then incubated
with 20 M hemin for 12 h to induce HO-1. For efficient
removal of BR generated during the induction period, the cells
and the flask were washed three times with the culturemedium
containing fetal bovine serum rather than PBS. Heme degrada-
tion was performed by incubating the cells in freshmedium (18
ml) containing 5 M hemin and 2 mM H2S at 37 °C. The screw
cap of the flask was closed during the reaction to suppress vol-
atilization of H2S. The medium was recovered after 2-h incu-
bation, centrifuged (3,000 rpm for 5 min), and supplemented
with propiophenone as an internal standard. Further addition
of a half-volume of saturated guanidine hydrochloride was fol-
lowed by solid-phase extraction and HPLC analysis as noted
above.
Preparation of HO intermediates
Ferric heme–HO-1 as purified was reduced by a slight excess
of dithionite anaerobically in the glove box to afford ferrous
deoxyheme–HO-1 to which 100 l of air was bubbled to yield
ferrous oxyheme–HO-1. Ferric hydroxyheme–HO-1 was gen-
erated in an anaerobic reaction of ferric heme–HO-1 with a
slight excess of H2O2 (47). Reaction of ferric heme–HO-1 with
H2O2 under air yields ferric verdoheme–HO-1 (48). Alterna-
tively, ferric verdoheme–HO-1 was generated upon oxidation
of ferrous verdoheme–HO-1, which was prepared as described
earlier (15), by 3 molar eq of potassium ferricyanide
(K3[Fe(CN)6]). The latter method enables completely anoxic
preparation of ferric verdoheme. Ferric biliverdin–HO-1 was
prepared from ferric heme–HO-1 by ascorbate-dependent
heme degradation.
Reaction of ferric verdoheme–HO-1with H2S
The ferric verdoheme complexwas prepared byH2O2 imme-
diately prior to use and used within 5 min after adding catalase
to remove the residual peroxide. Reactions with alkyl thiols
were performed in the presence of CO to suppress auto-oxi-
dation of ferrous verdoheme. Kinetic analysis of ferric ver-
doheme–HO-1 with H2S was performed at 20 °C using a
UNISOKU RSP-601 stopped-flow apparatus equipped with a
built-in rapid scan spectrophotometer. The ferric verdoheme
complex (3 M) was mixed with equal volumes of H2S solution
(final concentration, 50–200 M). Observed rate constants
determined from absorbance change at 683 nm exhibited good
linear relationships with the H2S concentrations to afford
apparent reaction rate constants (kapp) at varied pH. pH depen-
dence of the kapp values (Fig. 3E) is well-fitted by assuming an
acid-base transition of H2S (pKa 7.0). Buffers used for the
kinetic analysis were: 0.1 M citrate, pH 6.0–7.0; phosphate, pH
6.5–7.5; HEPES, pH 7.0–8.0; and Tris-HCl, pH 7.5–8.5.
Product formation from X
The intermediate Xwas prepared anaerobically from ferrous
verdoheme as noted above. The reductive titration to SBR was
performed under anoxic condition while monitoring absor-
bance increase at 541 nm. Formal two-electron reduction of
SBV to SBR was confirmed for the stable 1-SBV isomer. To
examineO2 dependence of the product distribution, the anoxic
X was mixed with air-saturated buffer to fill the screw-top
cuvette. Products were quantitated by HPLC analysis. For iso-
tope labeling of BV generated through O2-dependent reaction
of X, the intermediate was prepared with a slight excess of non-
Alternative heme degradation induced by H2S
J. Biol. Chem. (2018) 293(43) 16931–16939 16937
 at TO
H
O
K
U
 U
N
IV
ERSITY
 on N
ovem
ber 28, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
labeled H2O2 and air, which was followed by addition of cata-
lase and bubbling with excess 18O2.
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